U.S. FDA approves new protocol for study on Bayer’s birth control device

FILE PHOTO: The logo of Bayer AG, February 24, 2014. REUTERS/Ina Fassbender/File Photo (Reuters) – The U.S. Food and Drug Administration on Thursday approved a new protocol for a post-marketing study of... Read more »

Indian regulator orders J&J to stop using raw material to make Baby Powder in India: source

NEW DELHI (Reuters) – India’s drugs regulator has ordered Johnson & Johnson (JNJ.N) to stop manufacturing its Baby Powder using raw materials in two of its Indian factories until test results prove... Read more »

Keep off teething necklaces, FDA urges parents after reported death

(Reuters) – Stay away from necklaces and bracelets used to relieve teething pain in infants, the U.S. health regulator warned parents and caregivers on Thursday, after reports of a death and several... Read more »

Pre-deployment insomnia linked to increased risk of PTSD for soldiers

(Reuters Health) – Soldiers who have insomnia before deployment may be more likely to develop post-traumatic stress disorder (PTSD) or experience suicidal thoughts than service members who don’t struggle to sleep before... Read more »

ER visits for physical ailments tied to self-harm risk

(Reuters Health) – Teens and young adults who visit emergency rooms for injuries or physical illnesses may be more likely to harm themselves afterward, a U.S. study suggests. Emergency room (ER) visits... Read more »

Indian regulator orders Johnson & Johnson to stop using raw material to make Baby Powder in India: source

NEW DELHI (Reuters) – India’s drugs regulator has ordered Johnson & Johnson (JNJ.N) to stop manufacturing its Baby Powder using raw materials in two of its Indian factories until test results prove... Read more »

Sierra Leone fruit bats infected with Ebola-like Marburg virus

FILE PHOTO: A health worker in protective clothing peers out from behind barriers marking the isolation ward where victims of the deadly Marburg virus are treated in the northern Angolan town of... Read more »

As Ebola threatens mega-cities, vaccine stockpile needs grow

LONDON, Dec 20 (Reuters) – Doubts are growing about whether the world’s emergency stockpile of 300,000 Ebola vaccine doses is enough to control future epidemics as the deadly disease moves out of... Read more »

Agenus shares soar after cancer therapy deal with Gilead

FILE PHOTO: A Gilead Sciences, Inc. logo is seen outside the company headquarters in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam (Reuters) – Shares of Agenus Inc surged as much... Read more »

Gilead, Agenus sign deal to develop immuno-oncology therapies

FILE PHOTO: A Gilead Sciences, Inc. logo is seen outside the company headquarters in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam (Reuters) – Gilead Sciences Inc has inked a collaboration... Read more »